You just read:

BiondVax to Provide Update of M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial at 18th MIXiii-BIOMED Conference

News provided by

BiondVax Pharmaceuticals Ltd.

13 May, 2019, 14:00 IDT